Stryker Corp. is poised to acquire Entellus Medical Inc. in a deal for $24 per share, valued at about $662 million. Plymouth, Minn.-based Entellus designs minimally invasive products in the ear, nose and throat (ENT) market and brought in $23 million in 3Q17. News of the impending merger drove Entellus (NASDAQ:ENTL) shares up above 50 percent during trade on Thursday. Entellus shares closed at $23.99. The firm's board unanimously signed off on the transaction. Read More
